Flerie AB (publ) (STO:FLERIE)

Sweden flag Sweden · Delayed Price · Currency is SEK
37.10
+0.05 (0.13%)
Mar 6, 2026, 5:24 PM CET
-17.83%
Market Cap 2.87B
Revenue (ttm) 2.80M
Net Income (ttm) -756.90M
Shares Out 77.46M
EPS (ttm) -9.71
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 20,027
Average Volume 25,909
Open 37.30
Previous Close 37.10
Day's Range 36.80 - 37.30
52-Week Range 33.80 - 47.70
Beta n/a
RSI 61.30
Earnings Date Mar 5, 2026

About Flerie AB

Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, Nordic, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2011
Employees 9
Stock Exchange Nasdaq Stockholm
Ticker Symbol FLERIE
Full Company Profile

Financial Performance

In 2025, Flerie AB's revenue was 2.80 million, an increase of 7.69% compared to the previous year's 2.60 million. Losses were -756.90 million, 232.0% more than in 2024.

Financial Statements

News

There is no news available yet.